625 related articles for article (PubMed ID: 25457560)
21. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
Haglund M; Kalaria R; Slade JY; Englund E
Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
[TBL] [Abstract][Full Text] [Related]
22. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
Chen K; Maley J; Yu PH
J Neurochem; 2006 Dec; 99(5):1413-24. PubMed ID: 17074066
[TBL] [Abstract][Full Text] [Related]
23. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
24. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
25. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
26. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
Thal DR; Walter J; Saido TC; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
[TBL] [Abstract][Full Text] [Related]
27. Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer's dementias.
Michno W; Koutarapu S; Camacho R; Toomey C; Stringer K; Minta K; Ge J; Jha D; Fernandez-Rodriguez J; Brinkmalm G; Zetterberg H; Blennow K; Ryan NS; Lashley T; Hanrieder J
J Neurochem; 2022 Nov; 163(3):233-246. PubMed ID: 36102248
[TBL] [Abstract][Full Text] [Related]
28. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.
Greenberg SM; Bacskai BJ; Hernandez-Guillamon M; Pruzin J; Sperling R; van Veluw SJ
Nat Rev Neurol; 2020 Jan; 16(1):30-42. PubMed ID: 31827267
[TBL] [Abstract][Full Text] [Related]
29. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
30. Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA).
Zhou G; Xiang T; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z
Eur J Pharmacol; 2023 Jan; 939():175446. PubMed ID: 36470443
[TBL] [Abstract][Full Text] [Related]
31. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
32. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
[TBL] [Abstract][Full Text] [Related]
33. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.
Allen N; Robinson AC; Snowden J; Davidson YS; Mann DM
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):136-48. PubMed ID: 23808763
[TBL] [Abstract][Full Text] [Related]
34. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease.
Thal DR; Griffin WS; de Vos RA; Ghebremedhin E
Acta Neuropathol; 2008 Jun; 115(6):599-609. PubMed ID: 18369648
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Ferrer I; Lizcano JM; Hernández M; Unzeta M
Neurosci Lett; 2002 Mar; 321(1-2):21-4. PubMed ID: 11872247
[TBL] [Abstract][Full Text] [Related]
36. Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.
Kumar-Singh S
Int J Mol Sci; 2009 Apr; 10(4):1872-1895. PubMed ID: 19468344
[TBL] [Abstract][Full Text] [Related]
37. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
[TBL] [Abstract][Full Text] [Related]
38. Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes.
Vargas-Soria M; Ramos-Rodriguez JJ; Del Marco A; Hierro-Bujalance C; Carranza-Naval MJ; Calvo-Rodriguez M; van Veluw SJ; Stitt AW; Simó R; Bacskai BJ; Infante-Garcia C; Garcia-Alloza M
Fluids Barriers CNS; 2022 Nov; 19(1):88. PubMed ID: 36345028
[TBL] [Abstract][Full Text] [Related]
39. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.
Inoue Y; Ueda M; Tasaki M; Takeshima A; Nagatoshi A; Masuda T; Misumi Y; Kosaka T; Nomura T; Mizukami M; Matsumoto S; Yamashita T; Takahashi H; Kakita A; Ando Y
Acta Neuropathol; 2017 Oct; 134(4):605-617. PubMed ID: 28478503
[TBL] [Abstract][Full Text] [Related]
40. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]